(IN BRIEF) QIAGEN’s QIAstat-Dx Meningitis/Encephalitis Panel has received FDA clearance, enabling faster and more accurate diagnosis of critical CNS infections like meningitis and encephalitis. This panel, the fourth QIAstat-Dx test approved in the U.S. in 2024, uses real-time PCR to … Read the full press release
(IN BRIEF) QIAGEN has announced FDA clearance for its QIAstat-Dx Respiratory Panel Mini, marking the third such approval for the QIAstat-Dx system in 2024. Tailored for outpatient settings, this panel quickly detects five common respiratory pathogens—including influenza strains and SARS-CoV-2—enabling … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged FDA approval, influenza strains, Nadia Aelbrecht, Outpatient Respiratory Diagnostics, QIAGEN, QIAstat-Dx Mini Panel, Rapid Results, safety, SARS-CoV-2
(IN BRIEF) QIAGEN Digital Insights has announced an expanded partnership with Neo4j, aiming to enhance biomedical data analysis for the biopharmaceutical industry. This collaboration will integrate Neo4j’s graph database and machine learning capabilities with QIAGEN’s extensive biomedical knowledge base. By … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Biomedical Data Analysis, Biopharma Industry, Dominic John, Neo4j, partnership, QIAGEN, Sudhir Hasbe, sustainability, USA
(IN BRIEF) QIAGEN has launched an upgraded version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), tailored for high-throughput next-generation sequencing (NGS) labs. The new release enhances performance metrics like turnaround time and diagnostic yield through … Read the full press release
(IN BRIEF) QIAGEN, a leading provider of molecular diagnostics and life sciences solutions, is significantly expanding its operations in the Middle East region. In early 2024, the company will open its regional headquarters in Riyadh, Saudi Arabia, to strengthen its … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged Middle East, Oman, partnership, QIAGEN, Riyadh HQ, Saudi Ministry of Health, Simona Grandits, sustainability, TB Screening Initiative
(IN BRIEF) QIAGEN is organizing the Global TB Clinical and Educational Summit 2023, running from October 17-19, with the theme “Tackling TB together: From awareness to action.” This summit highlights QIAGEN’s dedication to combat tuberculosis (TB) and address the gap … Read the full press release
(IN BRIEF) QIAGEN has launched the QIAseq Normalizer Kits, a new solution for researchers to efficiently pool different DNA libraries for optimal results in next-generation sequencing (NGS) runs. The kit accelerates the process of normalizing DNA concentrations across libraries, reducing … Read the full press release
(IN BRIEF) QIAGEN has entered into a partnership with global pharmaceutical group, Servier, to develop a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor used to treat acute myeloid leukemia (AML). QIAGEN will develop and validate a real-time … Read the full press release
13 new kits and assays allow for quantification of AAV viral titer and residual host cell DNA in cell and gene therapy Custom assay design provides dPCR users with access to tailored multiplex assays for use beyond biopharma applications Milestone … Read the full press release
Posted in Business, Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged AAV, adeno-associated virus, biopharma, Cell and Gene Therapy, CGT, Dana Cipriano, digital PCR, DNA, dPCR, dPCR Assays, good manufacturing practice, imaging, QIAcuity, QIAGEN, qPCR, Residual DNA Quantification Kits, thermocycling, Thomas Schweins
13 nouveaux kits et tests permettent de quantifier le titre viral d’AAV et l’ADN résiduel de la cellule hôte en thérapie cellulaire et génique La conception de tests personnalisés permet aux utilisateurs de dPCR d’accéder à des tests multiplex personnalisés … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech, Science, Technology
Tagged AAV, adeno-associated virus, biopharma, Cell and Gene Therapy, CGT, Dana Cipriano, digital PCR, DNA, dPCR, dPCR Assays, good manufacturing practice, imaging, QIAcuity, QIAGEN, qPCR, Residual DNA Quantification Kits, thermocycling, Thomas Schweins
13 neue Kits und Tests ermöglichen die Quantifizierung von AAV-Titern und restlicher Wirtszell-DNA in der Zell- und Gentherapie Custom Assay Design Service bietet Nutzern von dPCR Zugang zu maßgeschneiderten Multiplex-Assays über den Einsatz in Biopharma-Anwendungen hinaus Meilenstein mit mehr als … Read the full press release
Posted in Business, Germany, Healthcare, Investment, News, Pharma & Biotech, Science, Technology
Tagged AAV, adeno-associated virus, Adeno-assoziiertes Virus, Bildgebung, biopharma, Cell and Gene Therapy, CGT, Dana Cipriano, digital PCR, digitale PCR, DNA, dPCR, dPCR Assays, dPCR-Assays, good manufacturing practice, gute Herstellungspraxis, imaging, QIAcuity, QIAGEN, qPCR, Residual DNA Quantification Kits, Rest-DNA-Quantifizierungskits, thermocycling, Thomas Schweins, Zell- und Gentherapie
HILDEN, Deutschland, GERMANTOWN, Maryland (USA), und SHANGHAI, China, 7-Feb-2022 — /EuropaWire/ — QIAGEN NV (NYSE: QGEN; Frankfurt Prime Standard: QIA), ein deutscher Anbieter von Sample-to-Insights-Lösungen, die es Kunden ermöglichen, Einblicke in die Bausteine des Lebens – DNA, RNA und Proteine … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged China National Medical Products Administration, Chinese Academy of Medical Sciences, Dr. Gao Lei, IGR, Interferon-Gamma Release Assays, Jean-Pascal Viola, NMPA, QFT-Plus, QIAGEN, QIAGEN NV, QIAreach QFT, QIAreach QuantiFERON-TB, QuantiFERON Tuberkulose, QuantiFERON-TB Gold Plus, TB-Bakterien, TB-Diagnose, TB-Infektionen, TB-Tests, TST, Tuberkulin-Hauttest, UNITAID, Weltgesundheitsorganisation, WHO
(COMMUNIQUÉ DE PRESSE) HILDEN, Germany / GERMANTOWN, MD, United Staes / SHANGHAI, 7-Feb-2022 — /EuropaWire/ — QIAGEN NV (NYSE : QGEN ; Frankfurt Prime Standard : QIA), une société allemande fournisseur de solutions Sample to Insights qui permettent aux clients de débloquer des informations sur … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech, Science, Technology
Tagged Académie chinoise des sciences médicales, bactérie de la tuberculose, dépistage de la tuberculose, diagnostic de la tuberculose, Dr. Gao Lei, IGR, infections tuberculeuses, Jean-Pascal Viola, NMPA, OMS, Organisation mondiale de la santé, QFT-Plus, QIAGEN, QIAGEN NV, QIAreach QFT, QIAreach QuantiFERON-TB, QuantiFERON tuberculosis, QuantiFERON-TB® Gold Plus, test cutané à la tuberculine, TST, UNITAID
(PRESS RELEASE) HILDEN, Germany / GERMANTOWN, MD, United Staes / SHANGHAI, 7-Feb-2022 — /EuropaWire/ — QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a German provider of Sample to Insights solutions that enable customers to unlock insights from the building … Read the full press release
Posted in Germany, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged China National Medical Products Administration, Chinese Academy of Medical Sciences, Dr. Gao Lei, IGR, Interferon-Gamma Release Assays, Jean-Pascal Viola, NMPA, QFT-Plus, QIAGEN, QIAGEN N.V., QIAreach QFT, QIAreach QuantiFERON-TB, QuantiFERON tuberculosis, QuantiFERON-TB Gold Plus, TB bacteria, TB diagnosis, TB infections, TB testing, TST, Tuberculin Skin Test, UNITAID, WHO, World Health Organization
Expanding range of applications for growing base of QIAcuity digital PCR instruments Two new collaborations: Atila BioSystems expands menu to non-invasive prenatal testing (NIPT), while Actome partnership designed to enable for the first time protein analysis using digital PCR technology … Read the full press release
(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release
Posted in Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged appointment, Assay technologies, Audit Committee, Bioinformatics, biomolecules, diagnostics, DNA, Dr. Toralf Haag, Lawrence Rosen, life sciences, Lonza Group AG, Molecular Diagnostics, QIAGEN, RNA, Sample to Insight, Supervisory Board, Thyssen Handelsunion AG, University of Augsburg, University of Kiel, Voith GmbH & Co. KGaA
Ergebnisse der Evaluierung der QCI-Plattform zur Interpretation klinisch relevanter Genvarianten werden auf der ASHG 2017 von Counsyl vorgestellt Orlando, Florida (USA), Germantown, Maryland (USA), und Hilden (Deutschland), 20-Oct-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurter Börse: QIA) gab heute bekannt, … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech, Society, Technology
Tagged ASHG 2017, Bioinformatik-Lösungen, Counsyl, Frauengesundheit, genetischer Tests, Genvarianten, QCI-Plattform, QIAGEN
Gold-standard test for latent tuberculosis infection will be covered by national health insurance Hilden, Germany, and Paris, France, 23-Jun-2017 — /EuropaWire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France’s Ministry of Health and Social Affairs … Read the full press release
Saluggia, Italy; Hilden, Germany, and Germantown, Maryland, USA, 23-Jun-2017 — /EuropaWire/ — DiaSorin (FTSE Italy Mid Cap: DIA) and QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) announced today a new collaboration to develop new tests for DiaSorin’s LIAISON family of … Read the full press release
Posted in Germany, Italy, Pharma & Biotech, Technology
Tagged Carlo Rosa, DiaSorin, Peer M. Schatz, QIAGEN, tests for DiaSorin’s LIAISON family of analyzers
High-throughput application of artus CMV QS-RGQ MDx Kit on QIAsymphony streamlines critical and frequently performed viral infection test for transplant patients Germantown, Maryland, and Hilden, Germany, 07-Jun-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has … Read the full press release
Posted in Germany, Healthcare, Pharma & Biotech
Tagged anti-CMV therapy, artus®, automated, CMV kit, CMV QS-RGQ MDx kit, QIAGEN, QIAsymphony platform, Thierry Bernard, U.S. FDA
Option to add new biomarkers for microsatellite instability (MSI) and mismatch repair (MMR) to QIAGEN’ s NGS panels Hilden, Germany, and Germantown, Maryland, 07-Jun-2017 — /EuropaWire/ — QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has received a worldwide … Read the full press release
NEW YORK and HILDEN, Germany, 06-Jun-2017 — /EuropaWire/ — Bristol-Myers Squibb Company (NYSE: BMY) and QIAGEN(NASDAQ: QGEN; Frankfurt Prime Standard: QIA) have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as … Read the full press release
World’s first complete Sample to Insight NGS solution proves equal or better compared with other sequencing workflows and alternative technologies Austin, Texas, and Hilden, Germany, 6-11-2015 — /EuropaWire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that an … Read the full press release
Posted in Germany, Healthcare, Netherlands, Pharma & Biotech
Tagged colorectal cancer, detecting gene variants, GeneReader NGS System, QIAGEN
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
